Results 201 to 210 of about 213,535 (253)
ABSTRACT Alzheimer's disease (AD) and Parkinson's disease (PD) are the most prevalent late‐onset neurodegenerative diseases worldwide. Both are influenced in part by genetic factors and are currently incurable. Tobacco and alcohol, the two most common substances used among the general adult population, are potential AD/PD risk factors and are also ...
Linda Wang +3 more
wiley +1 more source
Glycated haemoglobin (HbA1c) levels and motor symptoms in Parkinson's disease. [PDF]
Choudhary N +3 more
europepmc +1 more source
Associations Between Multiple Chemosensory Dysfunction and Cognition
Key Points This study supports the association between chemosensory dysfunction and cognition. We introduce methods of assessing trigeminal function with the Medoc TSA‐II thermoprobe. Our results identify an association between subjective trigeminal dysfunction and cognition.
Michelle Yu +5 more
wiley +1 more source
Research Progress on the Mechanism of Ginsenosides in the Treatment of Parkinson's Disease. [PDF]
Wang S +5 more
europepmc +1 more source
The gut–brain axis is a bidirectional communication network between the intestines and brain, mediated by gut microbiota and exosomes, that regulates neuroinflammation, protein aggregation, and neuronal health processes central to neurodegenerative diseases.
Waheeb Sami Aggad +9 more
wiley +1 more source
Stigma and social symptoms in Parkinson's disease: A scoping review. [PDF]
Gaiera F +4 more
europepmc +1 more source
At the genomic level, a large number of differentially expressed genes (DEGs) and aging‐related DEGs have been screened. Ten hub genes, such as IFNγ and IRF7, have been identified and shown potential value in the diagnosis of PD, holding promise as novel biomarkers to facilitate early and precise diagnosis.
Haojie Wu +3 more
wiley +1 more source

